Yakub Kadernani M.Sc, BPharm. presented his abstract #2048 today, November 18, 2026 at the World Conference on Lung Health 2026. The abstract was one of seven presentations accepted for the conference this year from team members of the “Bring BPaL2Me Trial – Comparing Nurse-Led RR-TB Treatment in Primary Care to Physician-Led, Hospital-Based RR-TB Treatment: A Cluster Randomized, Non-Inferiority Trial.” His oral presentation was entitled “Anaemia incidence, timing, and resolution in the Bring BPaL2Me Trial: A blinded interim safety analysis of nurse- or physician-managed RR-TB treatment in South African primary care. The interim report main safety finding showed no statistically significant difference between the blinded arms in anaemia incidence, timing, severity, or recovery overall or by sex or HIV status. Mr. Kadernani is the clinical trial coordinator and senior research program coordinator of the Bring BPaL2Me Trial.
Enjoy some photos of his presentation at the conference.




